<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7305759\results\search\zoonosis\results.xml">
  <result pre="and also by viral infectious agents such as influenza viruses," exact="Ebola" post="viruses, SARS-CoV-1, MERS-CoV, the Zika virus, and lately, SARS-CoV-2,"/>
  <result pre="and blocks the release of viral particles from host cells" exact="Influenza" post="Remdesivir â€&quot; Nucleotide analog inhibitor of RNA-dependent RNA polymerase"/>
  <result pre="Remdesivir â€&quot; Nucleotide analog inhibitor of RNA-dependent RNA polymerase (RdRp)" exact="Ebola" post="virus Umifenovir Arbidol Viral fusion inhibition with the targeted"/>
  <result pre="analog, was developed between 2014 and 2016 in response to" exact="Ebola" post="(Tchesnokov etÂ al., 2019). Similar to its promising effect"/>
  <result pre="2020). Notably, yet there is no FDA-approved therapy for neither" exact="Ebola" post="nor Zika virus, but promising clinical research is ongoing."/>
  <result pre="2018). However, lack of data of the pathophysiology of the" exact="SARS-CoV-2 infection" post="restrains the development of small molecule candidates based on"/>
  <result pre="rhesus macaques infected with SARS-CoV-2BioRxiv202010.1101/2020.03.13.990226 BeigelJ.H.TomashekK.M.DoddL.E.MehtaA.K.ZingmanB.S.KalilA.C.HohmannE.ChuH.Y.LuetkemeyerA.KlineS.Remdesivir for the treatment of" exact="Covid-19" post="â€&quot; preliminary reportN.Â Engl. J. Med.202010.1056/NEJMoa2007764 BoldescuV.BehnamM.A.M.VasilakisN.KleinC.D.Broad-spectrum agents for"/>
  <result pre="family clusterLancet395202051452331986261 ChenN.ZhouM.DongX.QuJ.GongF.HanY.QiuY.WangJ.LiuY.WeiY.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet395202050751332007143 ChenW.LanY.YuanX.DengX.LiY.CaiX.LiL.HeR.TanY.DengX.Detectable 2019-nCoV viral"/>
  <result pre="indicator for the further clinical severityEmerging Microbes Infect.92020469473 CohnS.KutalekR.Historical parallels," exact="Ebola" post="virus disease and cholera: understanding community distrust and social"/>
  <result pre="genetic discoveries into effective therapiesHum. Mol. Genet.252016R94R9827340225 GuanW.-j.NiZ.-y.HuY.LiangW.-H.OuC.-Q.HeJ.-X.LiuL.ShanH.LeiC.-l.HuiD.S.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaNew Engl. J. Med.38220201708172032109013 HayM.ThomasD.W.CraigheadJ.L.EconomidesC.RosenthalJ.Clinical development success rates"/>
  <result pre="molecular targets for known drugsNature462200917518119881490 KilianskiA.MielechA.M.DengX.BakerS.C.Assessing activity and inhibition of" exact="Middle East respiratory syndrome" post="coronavirus papain-like and 3C-like proteases using luciferase-based biosensorsJ.Â Virol.872013119551196223986593"/>
  <result pre="asymptomatic contact in GermanyNew Engl. J. Med.382202097097132003551 SandersJ.M.MonogueM.L.JodlowskiT.Z.CutrellJ.B.Pharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): a reviewJAMA323202018241836 SanseauP.AgarwalP.BarnesM.R.PastinenT.RichardsJ.B.CardonL.R.MooserV.Use of genome-wide association studies for"/>
  <result pre="continuing evolution of SARS-CoV-2Natl. Sci. Rev.7202010121023 TchesnokovE.P.FengJ.Y.PorterD.P.GÃ¶tteM.Mechanism of inhibition of" exact="Ebola" post="virus RNA-dependent RNA polymerase by remdesivirViruses112019326 TuranliB.AltayO.BorÃ©nJ.TurkezH.NielsenJ.UhlenM.ArgaK.Y.MardinogluA.Systems biology based"/>
  <result pre="vitroCell Res.30202026927132020029 WangY.WangY.ChenY.QinQ.Unique epidemiological and clinical features of the emerging" exact="2019 novel coronavirus pneumonia" post="(COVID-19) implicate special control measuresJ.Â Med. Virol.92202056857632134116 WangY.ZhangD.DuG.DuR.ZhaoJ.JinY.FuS.GaoL.ChengZ.LuQ.Remdesivir in"/>
  <result pre="of anti-inflammatoryÂ drugs in the treatment of people with severe" exact="coronavirus disease 2019" post="(COVID-19): the experience of clinical immunologists from ChinaClin. Immunol.214202010839332222466"/>
 </snippets>
</snippetsTree>
